Clinical Predictors for Germline Mutations in Head and Neck Paraganglioma Patients: Cost Reduction Strategy in Genetic Diagnostic Process as Fall-OutHartmut P.H. Neumann, Alexander Glien, Mercedes Robledo et al.|Cancer Research|2009Cited by 196
KRAS-Mutation Positive, Metastatic Tonsil Carcinoma With Cancer Stem-Like Cell Features and Long-Term Response to Gefitinib: A Case Report and Review of the LiteratureSandra Gottschling, Thomas Kuhnt, Roland Penzel et al.|Journal of Clinical Oncology|2011Cited by 6